“…All three cysteine residues in the epitope peptide were replaced with aminobutyric acid to prevent interpeptide disulfide bonding (25). This variant peptide was shown to be recognized by CD8 + T cells specific for gag 75-83 /D b (25). Abs to the following molecules were purchased from BD Biosciences (CD3, CD4, CD8, Ter119, and CD11b), BioLegend (CD43 [1B11], CD25, PD-1, CD69, CD62L, CD122, CD127, Tim-3, LAG-3, CTLA-4, FasL, TRAIL, PD-L1, PD-L2, CD11c, and FoxP3), or Invitrogen (Carlsbad, CA; granzyme B).…”